SEC Form 4 · accession 0001645766-18-000008

TransUnion · TRU

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP - Healthcare

Period of report

Jul 30, 2018

Accepted (ET)

Aug 1, 2018 · 6:28 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001552033

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 30, 2018	M	62,752	$13.06	A	99,390	D
Common Stock^F1,F2	Jul 30, 2018	S	62,752	$70.61	D	37,049	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (right to buy)^F3	$13.06	Jul 30, 2018	M	62,752	D	—	Jul 1, 2024	Common Stock	62,752	62,085	D

F1The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.38 to $70.77, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2Includes 411 shares of common stock acquired pursuant to the issuer's employee stock purchase plan since the reporting person's last report.
F3Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter.